Overview
Mitchell Binder is a Hematologist Oncology specialist and a Hematologist in Clovis, New Mexico. Dr. Binder and is rated as an Experienced provider by MediFind in the treatment of Prothrombin Deficiency. His top areas of expertise are EGFR Positive Lung Cancer, Small Cell Lung Cancer (SCLC), Large-Cell Lung Carcinoma, and Squamous Cell Lung Carcinoma. Dr. Binder is currently accepting new patients.
Insurance
Please contact the provider to confirm they accept your insurance or if you don't see your insurance listed.
Accepted insurance plans
- Humana
Locations
2200 W 21st St, Clovis, NM 88101
2400 Unser Blvd Se, Rio Rancho, NM 87124
8300 Constitution Ave Ne, Albuquerque, NM 87110
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
MediFind cannot find any recent clinical research or clinical trials for Dr. Mitchell J. Binder
Areas of Expertise
When evaluating expertise, MediFind pulls from factors such as the number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
To learn more about how MediFind determines the expertise levels, check out our expert tiers page.
- Distinguished
- ALK-Positive Non-Small Cell Lung Cancer
- EGFR Positive Lung Cancer
- Large-Cell Lung Carcinoma
- Lung Adenocarcinoma
- Non-Small Cell Lung Cancer (NSCLC)
- Small Cell Lung Cancer (SCLC)
- Advanced
- Acute Mountain Sickness
- Angiosarcoma
- Breast Cancer
- Dendritic Cell Tumor
- Hemophagocytic Lymphohistiocytosis
- Inflammatory Breast Cancer
- Experienced
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)
- Adult Immune Thrombocytopenia
- Adult Soft Tissue Sarcoma
- Agranulocytosis